Sign up to save your podcasts
Or
Share Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
In the first segment, Dr. Lindsay Higdon talks with Dr. Ivan Sanchez Fernandez about his paper on the meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Fauci about the measles outbreak of 2019. You can read the paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.
View all episodes
By American Academy of Neurology
4.7
283283 ratings
In the first segment, Dr. Lindsay Higdon talks with Dr. Ivan Sanchez Fernandez about his paper on the meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Fauci about the measles outbreak of 2019. You can read the paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.
More shows like Neurology® Podcast
View all
NEJM This Week
320 Listeners
JAMA Clinical Reviews
495 Listeners
Practical Neurology Podcast
50 Listeners
Mayo Clinic Talks
291 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,152 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
196 Listeners
Navigating Neuropsychology
361 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
132 Listeners
Neurology Exam Prep Podcast
179 Listeners
The Curious Clinicians
369 Listeners
Continuum Audio
79 Listeners